$AZTA News

Azenta: Needs To Overcome A Few Hurdles If The Rally Is To Continue

Evercore ISI Group Maintains Outperform on Azenta, Raises Price Target to $35

Needham Maintains Buy on Azenta, Raises Price Target to $37

Azenta, Inc. (AZTA) Q3 2026 Earnings Call Transcript

Azenta, Inc. 2026 Q3 - Results - Earnings Call Presentation

Azenta Narrows FY2026 Sales Guidance from $603.000M-$621.000M to $613.000M-$618.000M vs $600.458M Est

Azenta Q3 Adj. EPS $0.16 Beats $0.11 Estimate, Sales $161.000M Beat $149.288M Estimate

Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks

Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report

Azenta’s Q1 Earnings Call: Our Top 5 Analyst Questions

Azenta, Inc. Q2 2026 Earnings Call Summary

Needham Maintains Buy on Azenta, Lowers Price Target to $33

Azenta Q2 Earnings Call Highlights

Azenta, Inc. (AZTA) Q2 2026 Earnings Call Transcript

Azenta, Inc. 2026 Q2 - Results - Earnings Call Presentation

Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029

Azenta Sees FY2026 Sales $603.000M-$621.000M vs $623.837M Est

Azenta Q2 Adj. EPS $0.08 Misses $0.12 Estimate, Sales $145.000M Miss $148.740M Estimate

Assessing Azenta (AZTA) Valuation After Recent Share Price Volatility

Evercore Cuts Azenta (AZTA) Price Target, Keeps Outperform Rating